Soluble urokinase plasminogen activation receptor-An emerging new biomarker of cardiovascular disease and critical illness

Nicole Cyrille, Pedro Villablanca, Harish Ramakrishna

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. More clinical trials on suPAR is in the future research agenda.

Original languageEnglish (US)
Pages (from-to)214-216
Number of pages3
JournalAnnals of Cardiac Anaesthesia
Volume19
Issue number2
DOIs
StatePublished - Apr 1 2016

Fingerprint

Plasminogen
Urokinase-Type Plasminogen Activator
Critical Illness
Cardiovascular Diseases
Biomarkers
Clinical Trials

Keywords

  • Biomarkers
  • Cardiovascular disease
  • Critical illness
  • Heart failure

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Soluble urokinase plasminogen activation receptor-An emerging new biomarker of cardiovascular disease and critical illness. / Cyrille, Nicole; Villablanca, Pedro; Ramakrishna, Harish.

In: Annals of Cardiac Anaesthesia, Vol. 19, No. 2, 01.04.2016, p. 214-216.

Research output: Contribution to journalArticle

@article{3685bbbe4c0b433d9b1b694e70e38452,
title = "Soluble urokinase plasminogen activation receptor-An emerging new biomarker of cardiovascular disease and critical illness",
abstract = "Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. More clinical trials on suPAR is in the future research agenda.",
keywords = "Biomarkers, Cardiovascular disease, Critical illness, Heart failure",
author = "Nicole Cyrille and Pedro Villablanca and Harish Ramakrishna",
year = "2016",
month = "4",
day = "1",
doi = "10.4103/0971-9784.179588",
language = "English (US)",
volume = "19",
pages = "214--216",
journal = "Annals of Cardiac Anaesthesia",
issn = "0971-9784",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "2",

}

TY - JOUR

T1 - Soluble urokinase plasminogen activation receptor-An emerging new biomarker of cardiovascular disease and critical illness

AU - Cyrille, Nicole

AU - Villablanca, Pedro

AU - Ramakrishna, Harish

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. More clinical trials on suPAR is in the future research agenda.

AB - Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. More clinical trials on suPAR is in the future research agenda.

KW - Biomarkers

KW - Cardiovascular disease

KW - Critical illness

KW - Heart failure

UR - http://www.scopus.com/inward/record.url?scp=84964826452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964826452&partnerID=8YFLogxK

U2 - 10.4103/0971-9784.179588

DO - 10.4103/0971-9784.179588

M3 - Article

C2 - 27052059

AN - SCOPUS:84964826452

VL - 19

SP - 214

EP - 216

JO - Annals of Cardiac Anaesthesia

JF - Annals of Cardiac Anaesthesia

SN - 0971-9784

IS - 2

ER -